Current events, press releases and news | Le Lézard
网页Le Lézard gathers news regarding technologies, sciences, business, health, environment, travelling, sports, leisure activities, transportation and more.
Expert Systems Celebrates Milestone in Clinical Development of ...
网页5 小时之前 · Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ratutrelvir, a SARS-CoV-2 Main protease (Mpro ...
Avidity Biosciences Announces FDA Removed Partial Clinical Hold …
网页4 小时之前 · SAN DIEGO, Oct. 3, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...
Avangrid Awarded $425M Federal Capacity Contract for Maine …
网页4 小时之前 · Avangrid, Inc. , a leading sustainable energy company and member of the Iberdrola Group, announced that the U.S. Department of Energy (DOE) selected Avangrid for a $425 million capacity contract ...
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in …
网页2024年9月14日 · Classified in: Health, Science and technology, Covid-19 virus Subjects: Photo/Multimedia, Conference, Contract/Agreement, Trade Show KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in ...
Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results …
网页2024年9月14日 · Statement: 1. GZR18 injection is an investigational drug and has not yet been approved in China. 2. Gan & Lee Pharmaceuticals does not recommend the use of any unapproved drugs/indications. ...
Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding ...
网页2024年8月27日 · Eli Lilly and Company today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the ...
Bayer to Unveil New Data From Its Phase III OASIS 3 Long-Term …
网页2024年9月4日 · Bayer will present detailed results from the Phase III long-term study OASIS 3, evaluating the efficacy and long-term safety of the investigational compound elinzanetant versus placebo, at the ...
Actualités, communiqués de presse et nouvelles | Le Lézard
网页Le Lézard regroupe des nouvelles traitant des technologies, sciences, affaires, santé, environnement, voyage, sport, loisir, du transport et plus encore.
Sidus Space Enhances LizzieSattm Constellation Operations via …
网页2024年9月19日 · The global Age-related Macular Degeneration drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust CAGR of 10.7%.